CAMBRIDGE, Mass., Aug. 4, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective August 1, 2023, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 2,669 shares…